about
The Cardiovascular Health in Ambulatory Care Research Team (CANHEART): using big data to measure and improve cardiovascular health and healthcare services.Identifying Patients With Atrial Fibrillation in Administrative Data.Prediction of emergent heart failure death by semi-quantitative triage risk stratification.What constitutes the standard of care?The effect of a charted history of depression on emergency department triage and outcomes in patients with acute myocardial infarction.Expanding Paramedicine in the Community (EPIC): study protocol for a randomized controlled trial.Cardiovascular disease rates, outcomes, and quality of care in Ontario Métis: a population-based cohort study.Effect of marriage on duration of chest pain associated with acute myocardial infarction before seeking care.Emergency department management of atrial fibrillation in the United States versus Ontario, Canada.Managing atrial fibrillation.Identifying predictors of cumulative healthcare costs in incident atrial fibrillation: a population-based studyEmergency department length of stay for patients requiring mechanical ventilation: a prospective observational study.Wait times in the emergency department for patients with mental illness.Approach to fever assessment in ambulatory cancer patients receiving chemotherapy: a clinical practice guideline.Speak fast, use jargon, and don't repeat yourself: a randomized trial assessing the effectiveness of online videos to supplement emergency department discharge instructions.The CANHEART health index: a tool for monitoring the cardiovascular health of the Canadian populationRegional variations in ambulatory care and incidence of cardiovascular events.Interventions Supporting Long-term Adherence aNd Decreasing cardiovascular events (ISLAND): Pragmatic randomized trial protocol.Opioid prescribing among cancer and non-cancer patients: Time trend analysis in the elderly using administrative data.Approach to evaluation of fever in ambulatory cancer patients receiving chemotherapy: A systematic review.Predictors and clinical outcomes of inpatient versus ambulatory management after an emergency department visit for atrial fibrillation: A population-based study.Early non-persistence with dabigatran and rivaroxaban in patients with atrial fibrillation.2016 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation.The Transition of Care Between Emergency Department and Primary Care: A Scoping Study.Management of Discharged Emergency Department Patients with a Primary Diagnosis of Hypertension: A Multicentre Study.Factors associated with 90-day death after emergency department discharge for atrial fibrillation.Patients with atrial fibrillation and an alternative primary diagnosis in the emergency department: a description of their characteristics and outcomes.A Population-Based Analysis of Outcomes in Patients With a Primary Diagnosis of Hypertension in the Emergency Department.Trajectory of performance status and symptom scores for patients with cancer during the last six months of life.ED triage of patients with acute myocardial infarction: predictors of low acuity triage.A Clinical Decision Instrument for 30-Day Death After an Emergency Department Visit for Atrial Fibrillation: The Atrial Fibrillation in the Emergency Room (AFTER) Study.Outcomes among patients discharged from the emergency department with a diagnosis of peripheral vertigo.A Decision Analysis of Percutaneous Left Atrial Appendage Occlusion Relative to Novel and Traditional Oral Anticoagulation for Stroke Prevention in Patients with New-Onset Atrial Fibrillation.The Long-Term Use of Warfarin Among Atrial Fibrillation Patients Discharged From an Emergency Department With a Warfarin Prescription.Does routine symptom screening with ESAS decrease ED visits in breast cancer patients undergoing adjuvant chemotherapy?Missed strokes using computed tomography imaging in patients with vertigo: population-based cohort study.A population-based description of atrial fibrillation in the emergency department, 2002 to 2010.Opioid prescription after pain assessment: a population-based cohort of elderly patients with cancer.Symptom clusters in a population-based ambulatory cancer cohort validated using bootstrap methods.The association of the palliative performance scale and hazard of death in an ambulatory cancer population.
P50
Q30887359-B1D986F6-73B8-4E8C-BFB5-5114400D1247Q31136741-733EDDEB-DAFC-4302-AEA7-FD04B87F9874Q33996881-12028945-3277-442F-90B8-A9938A6D0B06Q34364197-D7236128-41E6-453B-A496-F1D0FE9AE5AFQ34765089-AE0C439D-FD86-4504-999C-5E3C2C938019Q34897690-5E44E368-0CA7-4D75-B8A6-CF6B4B42996DQ35202641-28CF1CB8-1754-40AF-A369-F34E48525636Q35223530-1E9467A6-6AEA-41EF-BEEC-2785E53B5678Q35900505-EC4BF620-F296-4219-AA1D-F8B48BDF5E83Q35900515-D77DCFEA-7EFF-49C6-8345-84FE535CC645Q36085718-59A58E5C-8DB1-4197-991C-B76AAD8F1E13Q36303249-6F8C27C6-10DA-42CF-AB7E-966518A82B3BQ36458365-ECDB72D8-2160-48BD-A5DC-A6EF5E008476Q37152897-658FA029-C811-43CD-91ED-1257C5300DABQ37297535-CA7D97DA-7E11-4234-AD29-83167BC414A2Q37591556-206CB8DC-024D-4015-99C0-EFE991D9E18CQ37735860-9BF9788F-B249-423E-9F86-C5C0BE9FEAFEQ38651201-42E1F2C4-07CC-4536-9803-6CFE6CEF3A1DQ38666532-BFC6AC9D-D384-426C-AE25-B2067835E72EQ38795572-412E8F19-DD66-4618-8592-9A1969F5F384Q38902764-B9E5615F-7007-47DB-BC1F-DB6CD92B404AQ38912202-DF061333-FBA7-4E7B-8856-4E7ACAE98E7AQ38949789-C22D6264-2FE2-414A-ABC0-D48C1C36BD1DQ38994988-249270BA-CB74-4C7B-9DE2-6153975BB024Q38996978-73513772-A024-4CD5-A67E-0F2E562E0776Q39446521-1ABD535A-2F02-4D98-952A-8B6F0105737AQ39468004-AACBF76D-D425-4E09-A6E2-B80C25758B03Q39617814-EB592FFC-5A2A-40C4-9D57-852FA02E5E11Q39785424-B005CCDB-7FEF-469B-92F8-51296630D1E0Q39856017-29A7B75A-E309-4D96-85EB-0284C0B6A169Q40521074-DAC12748-94D3-4FFC-B5E6-E6AB8B962F4CQ40523919-8CF111FF-EBFF-47D5-8FA6-4341D2D52DC5Q40771901-ECAEECCC-608F-49EF-97D8-CC5416ABAA5EQ40950131-ED9B356A-725F-4942-B01F-823166B19659Q41357319-8919882F-8347-4B4D-BCFB-D061DE69E7BEQ41725339-3C637C69-7B1C-45EE-BCF7-6B9D924A14E3Q43431273-0944C488-AA50-4652-9C38-F0B32070C545Q44333121-A56839E5-15F0-4190-988E-D791E260AF47Q44493247-D121D7F6-393E-419A-A6EB-01F872E2B497Q45346399-71513E32-7F3E-4A01-8127-8D158F260D89
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Clare L Atzema
@nl
Clare L Atzema
@sl
Clare L. Atzema
@en
Clare L. Atzema
@es
type
label
Clare L Atzema
@nl
Clare L Atzema
@sl
Clare L. Atzema
@en
Clare L. Atzema
@es
prefLabel
Clare L Atzema
@nl
Clare L Atzema
@sl
Clare L. Atzema
@en
Clare L. Atzema
@es
P106
P108
P1153
6602298009
P21
P31
P496
0000-0002-7236-5522